NCT05163652

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) Based on Different COVID-19 Inactivated Vaccine in Adults Aged 18 Years and Above

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) Based on the Basic Immunity of Different COVID-19 Inactivated Vaccine in Adults Aged 18 Years and Above

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 432 (estimated)
• Sponsor: Chinese Academy of Medical Sciences · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

To evaluate the immunogenicity and safety of the third dose SARS-CoV-2 Vaccine, Inactivated (Vero Cell) in adults aged 18 years and above, who inoculated the third dose after 3, 4, 5, or 6 months since finished two doses schedule of CoronaVac or BBIBP-CorV.

Conditions

• SARS-CoV-2 Infection

Interventions

Type	Name	Description
BIOLOGICAL	SARS-CoV-2 Vaccine, Inactivated (Vero Cell)	the third dose immunization schedule of SARS-CoV-2 inactivated vaccine

Timeline

• Start date: 2021-12-18
• Primary completion: 2022-08-30
• Completion: 2022-10-30
• First posted: 2021-12-20
• Last updated: 2022-03-02

Locations

1 site across 1 country: China